Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Read More » February 18, 2025
Overcoming the Donor Selection Challenges to Drive Success in Cell and Gene Therapy Development and Commercialization Read More » August 3, 2023
Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom: Recap of the Allogeneic Cell Therapies Summit 2023 Read More » June 20, 2023
Creating a Robust Donor Ecosystem to Accelerate Patient Access to Cell and Gene Therapies Read More » April 26, 2023
The Crucial Role of HLA Typing in Donor Selection for Cell and Gene Therapies Read More » March 28, 2023
FAQ Blog Series: What’s the Difference between Positive and Negative Immunomagnetic Cell Separation? Read More » March 14, 2023
The World’s Largest Apheresis Network Serves as a Catalyst to Advance Cell and Gene Therapies Read More » February 27, 2023
Navigating the complex world of regulations: How AllCells is changing cell therapy and protecting against product-ending events Read More » February 23, 2023
